Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (291-300 of 460) with videos related to

Pageof 46
Sort By:
JCI Insight|November 2, 2019
Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cellYanran He, Karin Schreiber, Steven P Wolf, et al.
Frontiers in Oncology|May 24, 2021
Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent GlioblastomaJoseph S Durgin, Fraser Henderson, MacLean P Nasrallah, et al.
British Journal of Haematology|March 13, 2021
B-cell maturation antigen chimeric antigen receptor T-cell re-expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor-based combination therapyLuca Bernabei, Lifeng Tian, Alfred L Garfall, et al.
Nature Cancer|April 11, 2024
Author Correction: Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissuesZijie Feng, Xin He, Xuyao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patientsKatia Schlienger, Christina S Chu, Edward Y Woo, et al.
Nature Cancer|March 22, 2022
Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissuesZijie Feng, Xin He, Xuyao Zhang, et al.
Cancer Research|May 17, 2015
Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal CellsAlbert Lo, Liang-Chuan S Wang, John Scholler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2008
Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignanciesXin Huang, Hongfeng Guo, Johnthomas Kang, et al.
Gastroenterology|March 24, 2018
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 TrialGregory L Beatty, Mark H O'Hara, Simon F Lacey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 13, 2020
Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected IndividualsJeffrey M Jacobson, Julie K Jadlowsky, Simon F Lacey, et al.
Pageof 46

Showing results (291-300 of 460) with videos related to

Sort By:
Pageof 46
JCI Insight|November 2, 2019
Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cellYanran He, Karin Schreiber, Steven P Wolf, et al.
Frontiers in Oncology|May 24, 2021
Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent GlioblastomaJoseph S Durgin, Fraser Henderson, MacLean P Nasrallah, et al.
British Journal of Haematology|March 13, 2021
B-cell maturation antigen chimeric antigen receptor T-cell re-expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor-based combination therapyLuca Bernabei, Lifeng Tian, Alfred L Garfall, et al.
Nature Cancer|April 11, 2024
Author Correction: Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissuesZijie Feng, Xin He, Xuyao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patientsKatia Schlienger, Christina S Chu, Edward Y Woo, et al.
Nature Cancer|March 22, 2022
Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissuesZijie Feng, Xin He, Xuyao Zhang, et al.
Cancer Research|May 17, 2015
Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal CellsAlbert Lo, Liang-Chuan S Wang, John Scholler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2008
Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignanciesXin Huang, Hongfeng Guo, Johnthomas Kang, et al.
Gastroenterology|March 24, 2018
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 TrialGregory L Beatty, Mark H O'Hara, Simon F Lacey, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 13, 2020
Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected IndividualsJeffrey M Jacobson, Julie K Jadlowsky, Simon F Lacey, et al.
Pageof 46